Clinical trials
Observational Adenocarcinoma of Lung trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 7 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 10 |
| Completed | 8 |
| Recruiting | 7 |
| Not yet recruiting | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 6 |
| Shanghai Pulmonary Hospital, Shanghai, China | 4 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 4 |
| Geneplus-Beijing Co. Ltd. | 3 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2 |
| Capital Medical University | 1 |
| First People's Hospital of Hangzhou | 1 |
| Maastricht University | 1 |
| Nanjing University | 1 |
| Peking University People's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma of Lung | 29 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Lung Neoplasms | 9 |
| Bronchial Neoplasms | 1 |
| Carcinoma, Bronchogenic | 1 |
| Cryptococcosis | 1 |
| Lung Diseases | 1 |
| Multiple Pulmonary Nodules | 1 |
| Neoplasms | 1 |
| Ovarian Neoplasms | 1 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.